This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allscripts Healthcare Solutions Management Discusses Q2 2012 Results - Earnings Call Transcript

Allscripts Healthcare Solutions (MDRX)

Q2 2012 Earnings Call

August 08, 2012 4:30 pm ET

Executives

Seth Frank - Vice President of Investor Relations

Glen E. Tullman - Chief Executive Officer, Executive Vice President and Director

W. David Morgan - Interim Chief Financial Officer and Senior Vice President of Finance

Analysts

Michael Cherny - ISI Group Inc., Research Division

Jamie Stockton - Wells Fargo Securities, LLC, Research Division

Atif A Rahim - JP Morgan Chase & Co, Research Division

Gregory T. Bolan - Sterne Agee & Leach Inc., Research Division

Andrew O'Hara

Charles Rhyee - Cowen and Company, LLC, Research Division

George Hill - Citigroup Inc, Research Division

Lawrence C. Marsh - Barclays Capital, Research Division

Alexander Y. Draper - Raymond James & Associates, Inc., Research Division

Eric W. Coldwell - Robert W. Baird & Co. Incorporated, Research Division

Sean W. Wieland - Piper Jaffray Companies, Research Division

Stephen B. Shankman - UBS Investment Bank, Research Division

Presentation

Operator

Good afternoon. My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to the Second Quarter 2012 Earnings Conference Call. [Operator Instructions] Seth Frank, Vice President of Investor Relations with Allscripts, you may begin your conference.

Seth Frank

Thanks, Sarah. Good afternoon, and thanks for joining us. With me on the call today are Glen Tullman, Allscripts' Chief Executive Officer; Dave Morgan, our interim Chief Financial Officer; and Lee Shapiro, our President.

[Operator Instructions] Before we begin, I'll briefly read the Safe Harbor statement.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASDAQ 4,776.5080 -51.8170 -1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs